263 related articles for article (PubMed ID: 36064348)
21. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H
Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630
[TBL] [Abstract][Full Text] [Related]
23. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-18a regulates the Pyroptosis, Apoptosis, and Necroptosis (PANoptosis) of osteoblasts induced by tumor necrosis factor-α via hypoxia-inducible factor-1α.
Zhang W; Xia CL; Qu YD; Li JX; Liu JB; Ou SJ; Yang Y; Qi Y; Xu CP
Int Immunopharmacol; 2024 Feb; 128():111453. PubMed ID: 38241841
[TBL] [Abstract][Full Text] [Related]
25. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells.
Sasabe E; Yang Z; Ohno S; Yamamoto T
Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165
[TBL] [Abstract][Full Text] [Related]
26. Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype.
Li L; Li C; Wang S; Wang Z; Jiang J; Wang W; Li X; Chen J; Liu K; Li C; Zhu G
Cancer Res; 2016 Apr; 76(7):1770-80. PubMed ID: 26992424
[TBL] [Abstract][Full Text] [Related]
27. LncRNA JPX regulates proliferation and apoptosis of nucleus pulposus cells by targeting the miR-18a-5p/HIF-1α/Hippo-YAP pathway.
Yang H; Wang G; Liu J; Lin M; Chen J; Fang Y; Li Y; Cai W; Zhan D
Biochem Biophys Res Commun; 2021 Aug; 566():16-23. PubMed ID: 34111667
[TBL] [Abstract][Full Text] [Related]
28. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
[TBL] [Abstract][Full Text] [Related]
29. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
30. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.
Shieh TM; Chang KW; Tu HF; Shih YH; Ko SY; Chen YC; Liu CJ
Oral Oncol; 2010 Sep; 46(9):e47-53. PubMed ID: 20656543
[TBL] [Abstract][Full Text] [Related]
31. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
32. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
[TBL] [Abstract][Full Text] [Related]
33. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
Li JN; Feng ZE; Wang L; Wang YX; Guo CB
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
[TBL] [Abstract][Full Text] [Related]
34. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factor-1alpha mediates oral squamous cell carcinoma invasion via upregulation of alpha5 integrin and fibronectin.
Ryu MH; Park HM; Chung J; Lee CH; Park HR
Biochem Biophys Res Commun; 2010 Feb; 393(1):11-5. PubMed ID: 20097172
[TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
[TBL] [Abstract][Full Text] [Related]
37. Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
Guimarães TA; Farias LC; Santos ES; de Carvalho Fraga CA; Orsini LA; de Freitas Teles L; Feltenberger JD; de Jesus SF; de Souza MG; Santos SH; de Paula AM; Gomez RS; Guimarães AL
Oncotarget; 2016 Aug; 7(34):55057-55068. PubMed ID: 27474170
[TBL] [Abstract][Full Text] [Related]
38. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the expression of microRNA-15a-5p and YAP1 gene in oral squamous cell carcinoma in comparison with normal tissue: A cross-sectional study.
Saravana Murthy P; Kannan A; Ganesan A; Lakshmi KC; Aniyan Kumbalaparambil Y
J Oral Pathol Med; 2023 Aug; 52(7):593-600. PubMed ID: 37285474
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
